Theradaptive
PrivateLast Round
Series B
Jan 12, 2026
Total Funding Raised
$49.9M
Company Overview
Theradaptive is a biotechnology company that develops a protein therapeutics platform designed to enable targeted delivery of recombinant proteins for applications in spine, orthopedics, soft tissue repair, and immuno-oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Theradaptive Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Theradaptive Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 12, 2026 | ||||
| Grant | Oct 2, 2025 | ||||
| Grant | May 22, 2024 | ||||
| Grant | Sep 26, 2023 | ||||
| Grant | Jul 6, 2023 | ||||
Series A | Jun 15, 2023 |
Key People
Founding team and executive leadership
Theradaptive Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TEDCO | Grant |
| U.S. Department of War | Grant |
| Maryland Stem Cell Research Fund | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 26, 2023
$7.4M grant received from the U.S. Department of War.
- Mar 1, 2023
Received $4M from the U.S. Department of War.
Theradaptive Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Theradaptive's valuation, stock price, and market status.